New imaging showdown: can MBI outperform DBT for dense breast cancer detection?
NCT ID NCT03220893
First seen Feb 03, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study compared two breast cancer screening methods—molecular breast imaging (MBI) and digital breast tomosynthesis (DBT)—in over 3,000 women aged 40-75 with dense breast tissue. MBI uses a small amount of radioactive material to spot active cancer cells, while DBT is a type of 3D mammogram. The goal was to see if adding MBI to standard DBT screening finds more invasive cancers early, when treatment is easier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, 54601, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, 43623, United States
Conditions
Explore the condition pages connected to this study.